Total Payments
$6,445
2024 Payments
$1,553
Companies
33
Transactions
312
Medicare Patients
45,941
Medicare Billing
$4.0M
Payment Breakdown by Category
Food & Beverage$6,029 (93.6%)
Education$415.44 (6.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,029 | 307 | 93.6% |
| Education | $415.44 | 5 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,037 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $1,006 | 49 | $0 (2024) |
| Journey Medical Corporation | $870.06 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $569.58 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $517.03 | 29 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $425.35 | 23 | $0 (2024) |
| Galderma Laboratories, L.P. | $203.20 | 15 | $0 (2024) |
| UCB, Inc. | $196.00 | 7 | $0 (2024) |
| LEO Pharma Inc. | $188.98 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $171.64 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,553 | 68 | Regeneron Healthcare Solutions, Inc. ($275.16) |
| 2023 | $1,399 | 65 | Janssen Biotech, Inc. ($448.13) |
| 2022 | $735.66 | 39 | ABBVIE INC. ($179.64) |
| 2021 | $641.19 | 21 | Journey Medical Corporation ($198.76) |
| 2020 | $128.59 | 7 | AbbVie Inc. ($60.94) |
| 2019 | $905.28 | 46 | AbbVie, Inc. ($233.46) |
| 2018 | $535.57 | 33 | AbbVie, Inc. ($91.92) |
| 2017 | $546.50 | 33 | Janssen Biotech, Inc. ($98.95) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.07 | General |
| 10/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Dermatology | ||||||
| 09/30/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.87 | General |
| 09/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Dermatology | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2024 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $111.66 | General |
| 09/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Oncology | ||||||
| 09/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 10,318 | 17,540 | $2.7M | $938,148 |
| 2022 | 46 | 11,007 | 18,111 | $2.3M | $1.0M |
| 2021 | 47 | 13,755 | 22,393 | $2.7M | $1.2M |
| 2020 | 45 | 10,861 | 17,659 | $2.1M | $845,782 |
Total Patients
45,941
Total Services
75,703
Medicare Billing
$4.0M
Procedure Codes
181
All Medicare Procedures & Services
181 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 2,177 | 2,924 | $541,101 | $189,752 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,460 | 1,945 | $508,833 | $178,088 | 35.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,826 | 2,615 | $363,881 | $116,529 | 32.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 1,143 | 1,312 | $277,458 | $102,326 | 36.9% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 22 | 397 | $97,435 | $38,277 | 39.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 1,255 | 5,608 | $77,814 | $29,943 | 38.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 116 | 119 | $75,240 | $23,554 | 31.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 522 | 573 | $66,491 | $23,318 | 35.1% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 120 | 129 | $55,088 | $20,337 | 36.9% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 38 | 62 | $48,441 | $18,989 | 39.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 164 | 201 | $47,531 | $17,766 | 37.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 304 | 401 | $41,966 | $16,763 | 39.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 102 | 116 | $43,057 | $15,189 | 35.3% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 75 | 82 | $32,137 | $11,571 | 36.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 145 | 145 | $33,342 | $11,123 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $29,645 | $10,139 | 34.2% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Office | 2023 | 26 | 27 | $25,006 | $9,959 | 39.8% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 54 | 55 | $31,854 | $9,531 | 29.9% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 53 | 57 | $22,854 | $8,580 | 37.5% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 33 | 33 | $21,242 | $8,060 | 37.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 40 | 42 | $21,350 | $7,750 | 36.3% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 35 | 44 | $21,085 | $6,593 | 31.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 39 | 47 | $16,505 | $6,303 | 38.2% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 25 | 28 | $18,290 | $6,027 | 33.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 53 | 55 | $14,420 | $5,708 | 39.6% |
About Dr. Daniel Herring, MD
Dr. Daniel Herring, MD is a Dermatology healthcare provider based in Cumberland, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1518089838.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Herring, MD has received a total of $6,445 in payments from pharmaceutical and medical device companies, with $1,553 received in 2024. These payments were reported across 312 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,029).
As a Medicare-enrolled provider, Herring has provided services to 45,941 Medicare beneficiaries, totaling 75,703 services with total Medicare billing of $4.0M. Data is available for 4 years (2020–2023), covering 181 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Cumberland, MD
- Active Since 04/06/2007
- Last Updated 07/19/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1518089838
Products in Payments
- TREMFYA (Drug) $745.13
- DUPIXENT (Biological) $569.58
- SKYRIZI (Biological) $412.39
- Humira (Biological) $332.68
- COSENTYX (Drug) $301.24
- Otezla (Drug) $237.44
- Exelderm (Drug) $223.23
- COSENTYX (Biological) $215.79
- Sotyktu (Drug) $171.64
- Bimzelx (Biological) $157.07
- HUMIRA (Biological) $153.28
- BLU-U (Medical Supply) $142.90
- Odomzo (Drug) $140.94
- ADBRY (Biological) $135.02
- EUCRISA (Drug) $119.27
- REMICADE (Biological) $110.83
- Zoryve (Drug) $103.50
- STELARA (Biological) $98.95
- EPIDUO FORTE (Drug) $98.52
- ILUMYA (Biological) $93.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.